Low-dose tamoxifen for combination hormone replacement therapy users

被引：3
|
作者：
Fabian, Carol J. [1 ]
机构：
[1] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 27期
关键词：
ITALIAN RANDOMIZED-TRIAL; ESTROGEN-PLUS-PROGESTIN; BREAST-CANCER; POSTMENOPAUSAL WOMEN; DENSITY; RISK; HYSTERECTOMY; PREVENTION;
D O I：
10.1200/JCO.2007.11.9743
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4162 / 4164
页数：3
相关论文
共 50 条
  • [31] Low-Dose Combination Therapy for Initial Treatment of Hypertension
    Emily R. Atkins
    Clara K. Chow
    Current Hypertension Reports, 2020, 22
  • [32] TAMOXIFEN AND NATURAL PROGESTERONE AS SUPPLEMENTS TO LOW-DOSE POSTMENOPAUSAL ESTROGEN THERAPY
    KAUPPILA, A
    KIVINEN, S
    STENBACK, F
    VIHKO, R
    VUOPALA, S
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1988, 25 (01) : 58 - 65
  • [33] Low-dose diuretic combination therapy in renal failure
    Knauf, H
    Mutschler, E
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1996, 25 (06) : 266 - 268
  • [34] A phase III prevention trial of low-dose tamoxifen in HRT users: The HOT trial
    Bonanni, Bernardo
    Maisonneuve, Patrick
    Serrano, Davide
    Varricchio, Clara
    Rotmensz, Nicole
    Cazzaniga, Massimiliano
    Lazzeroni, Matteo
    Santillo, Barbara
    Di Pace, Raffaella
    Latronico, Antuono
    Belloni, Carlo
    Del Turco, Marco Rosselli
    Segnan, Nereo
    Masullo, Pietro
    Andreoli, Claudio
    Monti, Nadia
    Vella, Alessandro
    D'Aiuto, Giuseppe
    Veronesi, Umberto
    De Censi, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] A cost-utility analysis of low-dose hormone replacement therapy in postmenopausal women with an intact uterus
    Swift, JA
    Conway, P
    Purdie, DW
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (12) : 2051 - 2061
  • [36] COMPARISON OF MEASURES OF BODY-COMPOSITION IN A TRIAL OF LOW-DOSE GROWTH-HORMONE REPLACEMENT THERAPY
    ORME, SM
    SEBASTIAN, JP
    OLDROYD, B
    STEWART, SP
    GRANT, PJ
    STICKLAND, MH
    SMITH, MA
    BELCHETZ, PE
    CLINICAL ENDOCRINOLOGY, 1992, 37 (05) : 453 - 459
  • [37] The prevention of osteoporosis using sequential low-dose hormone replacement therapy with estradiol-17β and dydrogesterone
    Lees, B
    Stevenson, JC
    OSTEOPOROSIS INTERNATIONAL, 2001, 12 (04) : 251 - 258
  • [38] The Prevention of Osteoporosis Using Sequential Low-Dose Hormone Replacement Therapy with Estradiol-17β and Dydrogesterone
    B. Lees
    J. C. Stevenson
    Osteoporosis International, 2001, 12 : 251 - 258
  • [39] Combination therapy of low-dose atorvastatin and fenofibrate in mixed hyperlipidemia
    Chatley, P.
    Badyal, D. K.
    Calton, R.
    Khosla, P. P.
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2007, 29 (03): : 217 - 221
  • [40] Low-dose combination therapy with perindopril and indapamide compared with irbesartan
    Morgan, T
    Anderson, A
    CLINICAL DRUG INVESTIGATION, 2002, 22 (08) : 553 - 560
12345